These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 37402019)

  • 1. Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application.
    Peng X; Zhang T; Liu R; Jin X
    Mol Cell Biochem; 2024 Jun; 479(6):1319-1333. PubMed ID: 37402019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases.
    Su Y; Chen M; Xu W; Gu P; Fan X
    ACS Nano; 2024 Aug; 18(34):22793-22828. PubMed ID: 39141830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome: From biology to drug delivery.
    Baruah H; Sarma A; Basak D; Das M
    Drug Deliv Transl Res; 2024 Jun; 14(6):1480-1516. PubMed ID: 38252268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
    Wang R; Gao Y; Liu A; Zhai G
    J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities.
    Zhang T; Jin X; Zhang N; Jiao X; Ma Y; Liu R; Liu B; Li Z
    Nanotechnology; 2022 Jan; 33(16):. PubMed ID: 34965522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
    Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
    Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome vesicle as a nano-therapeutic carrier for breast cancer.
    Mughees M; Kumar K; Wajid S
    J Drug Target; 2021 Feb; 29(2):121-130. PubMed ID: 32787592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
    Durgun ME; Güngör S; Özsoy Y
    J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated review on exosomes: biosynthesis to clinical applications.
    Modani S; Tomar D; Tangirala S; Sriram A; Mehra NK; Kumar R; Khatri DK; Singh PK
    J Drug Target; 2021 Nov; 29(9):925-940. PubMed ID: 33709876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to the eye: what benefits do nanocarriers offer?
    Joseph RR; Venkatraman SS
    Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
    Sharma Y; Patel P; Kurmi BD
    Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
    Andonova VY
    Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy.
    Zhao W; Li K; Li L; Wang R; Lei Y; Yang H; Sun L
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome: a significant nano-scale drug delivery carrier.
    Peng H; Ji W; Zhao R; Yang J; Lu Z; Li Y; Zhang X
    J Mater Chem B; 2020 Sep; 8(34):7591-7608. PubMed ID: 32697267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.